Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and Alzheimer's Disease
作者： Fernando Dangond
DOI:
关键词:
摘要: The present invention provide therapies for Alzheimer's Disease (AD), multiple sclerosis (MS) and amyotrophic lateral (ALS). method relies on the use of an HDAC inhibitor, alone or in combination with other drugs, to prevent treat AD, MS ALS. Also provided are methods screening additional inhibitors particular efficacy against these disease states.
lens.org 参考文章(6)
Laszlo Bodai, Judit Pallos, J. Lawrence Marsh, Joan S. Steffan, Leslie M. Thompson, Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors ,(2002)
Jeffrey Besterman, Zuomei Li, Claire Bonfils, Antisense oligonucleotide inhibition of specific histone deacetylase isoforms ,(2001)
Richard A. Rifkind, Victoria M. Richon, Paul A. Marks, Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors ,(2005)
Lisa M. Butler, Richard A. Rifkind, Victoria M. Richon, Paul A. Marks, Method of treating trx mediated diseases ,(2003)
Paul A. Marks, Victoria M. Richon, Thomas Miller, William Kevin Kelly, Histone deacetylase inhibitors Advances in Cancer Research. ,vol. 91, pp. 137- 168 ,(2006) , 10.1016/S0065-230X(04)91004-4
Jeffrey M. Besterman, Silvana Leit, Isabelle Paquin, Arkadii Vaisburg, Oscar Moradei, Tammy C. Mallais, Pierre Tessier, Sylvie Frechette, Inhibitors of Histone Deacetylase ,(2007)